Biodyne Co., Ltd. (KOSDAQ:314930)
South Korea
· Delayed Price · Currency is KRW 15,770
+20 (0.13%)
At close: Dec 5, 2025
Biodyne Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Other Revenue | 0 | - | - | - | -0 | - | Upgrade
|
| Revenue | 4,981 | 5,271 | 4,089 | 12,210 | 3,763 | 3,671 | Upgrade
|
| Revenue Growth (YoY) | 8.97% | 28.93% | -66.52% | 224.47% | 2.51% | -10.23% | Upgrade
|
| Cost of Revenue | 1,963 | 2,834 | 3,404 | 2,905 | 3,265 | 3,192 | Upgrade
|
| Gross Profit | 3,017 | 2,438 | 684.27 | 9,305 | 498.56 | 479.17 | Upgrade
|
| Selling, General & Admin | 3,044 | 3,027 | 1,829 | 1,828 | 2,122 | 1,600 | Upgrade
|
| Research & Development | 275.15 | 251.76 | 382.73 | 412.33 | 390.67 | 445.4 | Upgrade
|
| Amortization of Goodwill & Intangibles | 855.33 | 473.19 | 85.41 | 66.49 | 12.73 | 8.24 | Upgrade
|
| Other Operating Expenses | 25.1 | 23.41 | 27.52 | 10.57 | 75.88 | 80.92 | Upgrade
|
| Operating Expenses | 4,480 | 4,168 | 2,735 | 2,622 | 2,842 | 2,306 | Upgrade
|
| Operating Income | -1,463 | -1,730 | -2,051 | 6,683 | -2,343 | -1,826 | Upgrade
|
| Interest Expense | -0.16 | -0.17 | -0.22 | -0.44 | -215.23 | -589.5 | Upgrade
|
| Interest & Investment Income | 597.25 | 587.38 | 718.05 | 439.18 | 63.82 | 3.23 | Upgrade
|
| Currency Exchange Gain (Loss) | 220.85 | 705.35 | 67.89 | 130.28 | 279.87 | -291.83 | Upgrade
|
| Other Non Operating Income (Expenses) | 2.02 | -19.12 | -60.94 | 63.19 | -8,923 | -2,636 | Upgrade
|
| EBT Excluding Unusual Items | -643.15 | -456.37 | -1,326 | 7,316 | -11,138 | -5,341 | Upgrade
|
| Gain (Loss) on Sale of Investments | 347.4 | 259.52 | 210.85 | 57.77 | - | 257.93 | Upgrade
|
| Gain (Loss) on Sale of Assets | 71.2 | 55.75 | -105.78 | -7.58 | -0.01 | 22.77 | Upgrade
|
| Pretax Income | -224.54 | -141.1 | -1,221 | 7,366 | -11,138 | -5,060 | Upgrade
|
| Income Tax Expense | -145.9 | -151.87 | -229.18 | 1,754 | -281.16 | -605.79 | Upgrade
|
| Net Income | -78.64 | 10.77 | -991.76 | 5,611 | -10,857 | -4,454 | Upgrade
|
| Net Income to Common | -78.64 | 10.77 | -991.76 | 5,611 | -10,857 | -4,454 | Upgrade
|
| Shares Outstanding (Basic) | 30 | 29 | 30 | 30 | 6 | 5 | Upgrade
|
| Shares Outstanding (Diluted) | 30 | 29 | 30 | 30 | 6 | 5 | Upgrade
|
| Shares Change (YoY) | 1.13% | -1.92% | 1.23% | 402.08% | 27.04% | 17.60% | Upgrade
|
| EPS (Basic) | -2.66 | 0.37 | -33.00 | 189.00 | -1836.00 | -957.00 | Upgrade
|
| EPS (Diluted) | -2.66 | 0.37 | -33.00 | 189.00 | -1836.00 | -957.00 | Upgrade
|
| Free Cash Flow | -1,724 | 338.26 | -264.7 | 1,151 | -1,341 | -759.85 | Upgrade
|
| Free Cash Flow Per Share | -58.31 | 11.48 | -8.81 | 38.76 | -226.74 | -163.25 | Upgrade
|
| Gross Margin | 60.58% | 46.25% | 16.73% | 76.21% | 13.25% | 13.05% | Upgrade
|
| Operating Margin | -29.38% | -32.81% | -50.16% | 54.73% | -62.27% | -49.75% | Upgrade
|
| Profit Margin | -1.58% | 0.20% | -24.26% | 45.95% | -288.50% | -121.34% | Upgrade
|
| Free Cash Flow Margin | -34.61% | 6.42% | -6.47% | 9.43% | -35.63% | -20.70% | Upgrade
|
| EBITDA | -60.28 | -107.9 | -385.37 | 8,241 | -999.01 | -610.68 | Upgrade
|
| EBITDA Margin | -1.21% | -2.05% | -9.43% | 67.49% | -26.55% | -16.63% | Upgrade
|
| D&A For EBITDA | 1,403 | 1,622 | 1,665 | 1,558 | 1,344 | 1,216 | Upgrade
|
| EBIT | -1,463 | -1,730 | -2,051 | 6,683 | -2,343 | -1,826 | Upgrade
|
| EBIT Margin | -29.38% | -32.81% | -50.16% | 54.73% | -62.27% | -49.75% | Upgrade
|
| Effective Tax Rate | - | - | - | 23.82% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.